Notícias Quince Therapeutics Inc - QNCX | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Quince Therapeutics Inc (QNCX)
Quince Therapeutics Inc (QNCX) Notícias

Quince Therapeutics Inc (QNCX)

1,85

0,01

(0,54%)

Fechado 19 Dezembro 6:00PM

Atrasado por 15 minutos

1,93

0,08

(4,32%)

Após o horário de negociação: 9:36PM

Atrasado por 15 minutos

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

Form S-3 - Registration statement under Securities Act of 1933

Form 8-K - Current report

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Quince Therapeutics Presents Data from Prior Phase 3 ATTeST Clinical Trial at 2024 International Congress for Ataxia Research

Quince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual Meeting

Quince Therapeutics to Participate at Upcoming Investor Conferences

Quince Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Form 4 - Statement of changes in beneficial ownership of securities

Quince Therapeutics Announces The Lancet Neurology Publication of Phase 3 ATTeST Clinical Trial Data Evaluating EryDex for the Treatment of Ataxia-Telangiectasia (A-T)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Quince Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Quince Therapeutics Announces First Patient Dosed in Phase 3 Clinical Trial of EryDex for the Treatment of Ataxia-Telangiectasia

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Quince Therapeutics

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições